ZNF77
Zinc finger protein 77
Also known as: pT1, ZNF77_HUMAN
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- Q15935
- Gene
- ZNF77
- Ensembl
- ENSG00000175691
- Chromosome
- 19
- Canonical length
- 545 aa
- Protein class
- Predicted intracellular proteins, Transcription factors
- Subcellular location
- Nucleoplasm,Nucleoli
OverviewNCBI Gene
Predicted to enable DNA-binding transcription factor activity, RNA polymerase II-specific and RNA polymerase II transcription regulatory region sequence-specific DNA binding activity. Predicted to be involved in regulation of transcription by RNA polymerase II. Predicted to be active in nucleus. [provided by Alliance of Genome Resources, Jul 2025]
Canonical amino-acid sequenceUniProt
545 residues, UniProt reviewed canonical sequence.
>Q15935|ZNF77
1 MDCVIFEEVA VNFTPEEWAL LDHAQRSLYR DVMLETCRNL ASLDCYIYVR TSGSSSQRDV
61 FGNGISNDEE IVKFTGSDSW SIFGENWRFD NTGDQHQIPQ RHLRSQLGRL CESNEGHQCG
121 ETLSQTANLL VHKSYPTEAK PSECTKCGKA FENRQRSHTG QRPCKECGQA CSCLSCQSPP
181 MKTQTVEKPC NCQDSRTASV TYVKSLSSKK SYECQKCGKA FICPSSFRGH VNSHHGQKTH
241 ACKVCGKTFM YYSYLTRHVR THTGEKPYEC KECGKAFSCP SYFREHVRTH TGEKPYECKH
301 CGKSFSCYSS FRDHVRTHTG EKPCQCKHCG KAFTCYSSLR EHGRTHSGEK PYECKECGKA
361 FRYPSSLRAH MRMHTGEKPY VCKQCGKAFG CPTYFRRHVK THSGVKPYQC KECGKAYSFS
421 SSLRIHVRTH TGEKPFECKH CGKAFSCHSS LREHVRTHSG EKPYECNQCG KAFSHAQYFQ
481 KHVRSHSGVK PYECTECGKA YSCSSSLRVH VRTHTGERPY ECKQCGKTFR YLASLQAHVR
541 THAGALocalizationUniProt · AlphaFold · HPA
Whether an antibody against ZNF77 can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Intracellular
- Secreted
- No
- Transmembrane segments
- 0
- Mean surface accessibility (rSASA)
- 0.44
- Highest tissue expression
- 5.1 nTPM
Expression across tissuesHPA
Tissue
- cerebellum: 5.1 nTPM
- breast: 4.3 nTPM
- tongue: 3.8 nTPM
- retina: 3.7 nTPM
- ovary: 3.5 nTPM
- testis: 3.4 nTPM
Single-cell type
- syncytiotrophoblasts: 21 nCPM
- myosatellite cells: 18 nCPM
- differentiating spermatogonia: 17 nCPM
- mucous neck cells: 17 nCPM
- early primary spermatocytes: 16 nCPM
- cytotrophoblasts: 11 nCPM
Immune cell
- memory B-cell: 3.7 nTPM
- MAIT T-cell: 3.5 nTPM
- naive B-cell: 3.5 nTPM
- naive CD8 T-cell: 3.4 nTPM
- memory CD8 T-cell: 3.2 nTPM
- memory CD4 T-cell: 3.1 nTPM
Brain region
- cerebellum: 8.3 nTPM
- white matter: 4.2 nTPM
- cerebral cortex: 3.9 nTPM
- amygdala: 3.5 nTPM
- midbrain: 3.5 nTPM
- pons: 3.5 nTPM
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 1.54
- gnomAD pLI
- 0
- gnomAD missense Z
- -0.34
- DepMap mean gene effect
- 0.05
- DepMap dependency class
- none
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 6% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
OntologyGO
Biological processes
Molecular functions
- DNA-binding transcription factor activity, RNA polymerase II-specific
- RNA polymerase II transcription regulatory region sequence-specific DNA binding
- zinc ion binding
Cellular components
Protein domainsUniProt · Pfam · InterPro
KeywordsUniProt
InteractionsUniProt · HPA
Protein binding partners of ZNF77 in the human serome: UniProt-annotated complex subunits plus reported interactors. Each links to its own Seroatlas record.
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads ZNF77 as an antibody target. Whether an autoantibody or antibody against ZNF77 could matter depends on whether native ZNF77 is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
ZNF77 is annotated as predominantly intracellular. Intracellular proteins are common autoantibody markers, becoming visible to the immune system after cell injury or altered processing, but are usually markers of disease rather than direct drivers.
Annotation status
The present source text does not explicitly label ZNF77 as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...